The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
Open accessAbstract
Osteosarcomas are the most frequent primary bone sarcomas, affecting mainly children, adolescents, and young adults, and with a second peak of incidence in elderly individuals. The current therapeutic management, a combined regimen of poly-chemotherapy and surgery, still remains largely insufficient, as patient survival has not improved in recent decades. Osteosarcomas are very heterogeneous tumors, both at the intra- and inter-tumor level, with no identified driver mutation. Consequently, efforts to improve treatments using targeted therapies have faced this lack of specific osteosarcoma targets. Nevertheless, these tumors are inextricably linked to their local microenvironment, composed of bone, stromal, vascular and immune cells and the osteosarcoma microenvironment is now considered to be essential and supportive for growth and dissemination. This review describes the different actors of the osteosarcoma microenvironment and gives an overview of the past, current, and future strategies of therapy targeting this complex ecosystem, with a focus on the role of extracellular vesicles and on the emergence of multi-kinase inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Molecular mechanisms and clinical applications of angiogenesis
Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., & Karsenty, G. (1997) · Cell · doi:10.1016/s0092-8674(00)80257-3 · Cited by 4,246
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
Kusumbe, A. P., Ramasamy, S. K., & Adams, R. H. (2014) · Nature · doi:10.1038/nature13145 · Cited by 2,155
Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry
Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M. G., Pe'er, J., Trent, J. M., Meltzer, P. S., & Hendrix, M. J. C. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65173-5 · Cited by 2,043
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Friedl, P., & Alexander, S. (2011) · Cell · doi:10.1016/j.cell.2011.11.016 · Cited by 1,940
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-hora, M., Feng, J. Q., Bonewald, L. F., Kodama, T., Wutz, A., Wagner, E. F., et al. (2011) · Nature Medicine · doi:10.1038/nm.2452 · Cited by 1,778
Translational biology of osteosarcoma
Kansara, M., Teng, M. W., Smyth, M. J., & Thomas, D. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3838 · Cited by 1,294
Endothelial Notch activity promotes angiogenesis and osteogenesis in bone
Ramasamy, S. K., Kusumbe, A. P., Wang, L., & Adams, R. H. (2014) · Nature · doi:10.1038/nature13146 · Cited by 1,071
Advances in therapeutic applications of extracellular vesicles
Wiklander, O. P. B., Brennan, M. Á., Lötvall, J., Breakefield, X. O., & EL Andaloussi, S. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8521 · Cited by 1,039
Ahmed, N., Brawley, V. S., Hegde, M., Robertson, C., Ghazi, A., Gerken, C., Liu, E., Dakhova, O., Ashoori, A., Corder, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0225 · Cited by 1,004
Ponte, A. L., Marais, E., Gallay, N., Langonné, A., Delorme, B., Hérault, O., Charbord, P., & Domenech, J. (2007) · STEM CELLS · doi:10.1634/stemcells.2007-0054 · Cited by 947
Exosomes maintain cellular homeostasis by excreting harmful DNA from cells
Takahashi, A., Okada, R., Nagao, K., Kawamata, Y., Hanyu, A., Yoshimoto, S., Takasugi, M., Watanabe, S., Kanemaki, M. T., Obuse, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15287 · Cited by 761
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Chen, X., Bahrami, A., Pappo, A., Easton, J., Dalton, J., Hedlund, E., Ellison, D., Shurtleff, S., Wu, G., Wei, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.003 · Cited by 752
Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.031 · Cited by 717
Transforming Growth Factor-β1 to the Bone
Janssens, K., ten Dijke, P., Janssens, S., & Van Hul, W. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0001 · Cited by 710
Vasculogenic Mimicry and Tumor Angiogenesis
Folberg, R., Hendrix, M. J. C., & Maniotis, A. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64739-6 · Cited by 684
Small molecules, big impact: 20 years of targeted therapy in oncology
Bedard, P. L., Hyman, D. M., Davids, M. S., & Siu, L. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30164-1 · Cited by 610
Identification of the Human Skeletal Stem Cell
Chan, C. K. F., Gulati, G. S., Sinha, R., Tompkins, J. V., Lopez, M., Carter, A. C., Ransom, R. C., Reinisch, A., Wearda, T., Murphy, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.029 · Cited by 595
Coupling of bone resorption and formation by RANKL reverse signalling
Ikebuchi, Y., Aoki, S., Honma, M., Hayashi, M., Sugamori, Y., Khan, M., Kariya, Y., Kato, G., Tabata, Y., Penninger, J. M., et al. (2018) · Nature · doi:10.1038/s41586-018-0482-7 · Cited by 557
Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508
Nassar, W., El-Ansary, M., Sabry, D., Mostafa, M. A., Fayad, T., Kotb, E., Temraz, M., Saad, A.-N., Essa, W., & Adel, H. (2016) · Biomaterials Research · doi:10.1186/s40824-016-0068-0 · Cited by 502
Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy
Gianferante, D. M., Mirabello, L., & Savage, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.16 · Cited by 477
Blood vessel formation and function in bone
Sivaraj, K. K., & Adams, R. H. (2016) · Development · doi:10.1242/dev.136861 · Cited by 441
Macrophages define the invasive microenvironment in breast cancer
Pollard, J. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107762 · Cited by 417
A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era
Allison, D. C., Carney, S. C., Ahlmann, E. R., Hendifar, A., Chawla, S., Fedenko, A., Angeles, C., & Menendez, L. R. (2012) · Sarcoma · doi:10.1155/2012/704872 · Cited by 404
Gong, M., Yu, B., Wang, J., Wang, Y., Liu, M., Paul, C., Millard, R. W., Xiao, D.-S., Ashraf, M., & Xu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.16778 · Cited by 399
Transcription factors controlling osteoblastogenesis
Marie, P. J. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.02.030 · Cited by 387
Grignani, G., Palmerini, E., Dileo, P., Asaftei, S. D., D’Ambrosio, L., Pignochino, Y., Mercuri, M., Picci, P., Fagioli, F., Casali, P. G., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr151 · Cited by 359
Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency
Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9940 · Cited by 353
Gonzalez-King, H., García, N. A., Ontoria-Oviedo, I., Ciria, M., Montero, J. A., & Sepúlveda, P. (2017) · Stem Cells · doi:10.1002/stem.2618 · Cited by 352
Grignani, G., Palmerini, E., Ferraresi, V., D'Ambrosio, L., Bertulli, R., Asaftei, S. D., Tamburini, A., Pignochino, Y., Sangiolo, D., Marchesi, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71136-2 · Cited by 340
Endogenous TGF‐β signaling suppresses maturation of osteoblastic mesenchymal cells
Maeda, S., Hayashi, M., Komiya, S., Imamura, T., & Miyazono, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600067 · Cited by 339
Vallabhaneni, K. C., Penfornis, P., Dhule, S., Guillonneau, F., Adams, K. V., Mo, Y. Y., Xu, R., Liu, Y., Watabe, K., Vemuri, M. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3211 · Cited by 332
Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., Delcambre, C., Kalbacher, E., Italiano, A., Collard, O., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30742-3 · Cited by 331
Italiano, A., Mir, O., Mathoulin-Pelissier, S., Penel, N., Piperno-Neumann, S., Bompas, E., Chevreau, C., Duffaud, F., Entz-Werlé, N., Saada, E., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30825-3 · Cited by 326
Fidler, I. J., Sone, S., Fogler, W. E., & Barnes, Z. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1680 · Cited by 324
A network of trans-cortical capillaries as mainstay for blood circulation in long bones
Grüneboom, A., Hawwari, I., Weidner, D., Culemann, S., Müller, S., Henneberg, S., Brenzel, A., Merz, S., Bornemann, L., Zec, K., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0016-5 · Cited by 307
(2000) · PubMed · Cited by 304
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02374 · Cited by 268
Future directions in the treatment of osteosarcoma
Bishop, M. W., Janeway, K. A., & Gorlick, R. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000298 · Cited by 268
Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30093 · Cited by 267
Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
Liu, K., Ren, T., Huang, Y., Sun, K., Bao, X., Wang, S., Zheng, B., & Guo, W. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.422 · Cited by 264
Liu, X., Li, Q., Niu, X., Hu, B., Chen, S., Song, W., Ding, J., Zhang, C., & Wang, Y. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.16951 · Cited by 255
Cells of origin in osteosarcoma: Mesenchymal stem cells or osteoblast committed cells?
Mutsaers, A. J., & Walkley, C. R. (2014) · Bone · doi:10.1016/j.bone.2014.02.003 · Cited by 233
Xue, C., Shen, Y., Li, X., Li, B., Zhao, S., Gu, J., Chen, Y., Ma, B., Wei, J., Han, Q., et al. (2018) · Stem Cells and Development · doi:10.1089/scd.2017.0296 · Cited by 232
MacEwen, E. G., Kurzman, I. D., Rosenthal, R. C., Smith, B. W., Manley, P. A., Roush, J. K., & Howard, P. E. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.12.935 · Cited by 228
Bone microenvironment signals in osteosarcoma development
Alfranca, A., Martinez-Cruzado, L., Tornin, J., Abarrategi, A., Amaral, T., de Alava, E., Menendez, P., Garcia-Castro, J., & Rodriguez, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1918-y · Cited by 223
Piperno-Neumann, S., Le Deley, M.-C., Rédini, F., Pacquement, H., Marec-Bérard, P., Petit, P., Brisse, H., Lervat, C., Gentet, J.-C., Entz-Werlé, N., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30096-1 · Cited by 219
Response to anti-PD1 therapy with nivolumab in metastatic sarcomas
Paoluzzi, L., Cacavio, A., Ghesani, M., Karambelkar, A., Rapkiewicz, A., Weber, J., & Rosen, G. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0064-0 · Cited by 218
Keung, E. Z., Burgess, M., Salazar, R., Parra, E. R., Rodrigues-Canales, J., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Attia, S., Riedel, R. F., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1824 · Cited by 215 · cited 1×
“However, PD-L1 staining was detected in few OS specimens in two independent studies [135,146], which suggested that the role of the PD1/PD-L1 checkpoint is not predominant in the pathogenesis of OS.”
BackgroundRANKL/OPG; Critical role in bone physiology
Martin, T. J., & Sims, N. A. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9308-6 · Cited by 213
Gangadaran, P., Rajendran, R. L., Lee, H. W., Kalimuthu, S., Hong, C. M., Jeong, S. Y., Lee, S.-W., Lee, J., & Ahn, B.-C. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.022 · Cited by 210
Nonomura, N., Takayama, H., Nakayama, M., Nakai, Y., Kawashima, A., Mukai, M., Nagahara, A., Aozasa, K., & Tsujimura, A. (2011) · BJU International · doi:10.1111/j.1464-410x.2010.09804.x · Cited by 197
Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
Lussier, D. M., O’Neill, L., Nieves, L. M., McAfee, M. S., Holechek, S. A., Collins, A. W., Dickman, P., Jacobsen, J., Hingorani, P., & Blattman, J. N. (2015) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000065 · Cited by 197
Characterization of Regulatory Extracellular Vesicles from Osteoclasts
Huynh, N., VonMoss, L., Smith, D., Rahman, I., Felemban, M. F., Zuo, J., Rody, W. J., McHugh, K. P., & Holliday, L. S. (2016) · Journal of Dental Research · doi:10.1177/0022034516633189 · Cited by 196
Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression
Baglio, S. R., Lagerweij, T., Pérez-Lanzón, M., Ho, X. D., Léveillé, N., Melo, S. A., Cleton-Jansen, A.-M., Jordanova, E. S., Roncuzzi, L., Greco, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2726 · Cited by 187
CAR T‐cell therapy: Full speed ahead
Sermer, D., & Brentjens, R. (2019) · Hematological Oncology · doi:10.1002/hon.2591 · Cited by 183
Lamoureux, F., Richard, P., Wittrant, Y., Battaglia, S., Pilet, P., Trichet, V., Blanchard, F., Gouin, F., Pitard, B., Heymann, D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4130 · Cited by 181
Self-citationGomez-Brouchet, A., Illac, C., Gilhodes, J., Bouvier, C., Aubert, S., Guinebretiere, J.-M., Marie, B., Larousserie, F., Entz-Werlé, N., de Pinieux, G., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331193 · Cited by 179
Nishimura, R., Wakabayashi, M., Hata, K., Matsubara, T., Honma, S., Wakisaka, S., Kiyonari, H., Shioi, G., Yamaguchi, A., Tsumaki, N., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337063 · Cited by 175
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
Dumars, C., Ngyuen, J.-M., Gaultier, A., Lanel, R., Corradini, N., Gouin, F., Heymann, D., & Heymann, M.-F. (2016) · Oncotarget · doi:10.18632/oncotarget.13055 · Cited by 174
Human type H vessels are a sensitive biomarker of bone mass
Wang, L., Zhou, F., Zhang, P., Wang, H., Qu, Z., Jia, P., Yao, Z., Shen, G., Li, G., Zhao, G., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.36 · Cited by 168
Bone cell interactions through Eph/ephrin: Bone modeling, remodeling and associated diseases
Matsuo, K., & Otaki, N. (2012) · Cell Adhesion & Migration · doi:10.4161/cam.20888 · Cited by 167
Biology of Bone: The Vasculature of the Skeletal SystemPreprint
Watson, E. L., & Adams, R. H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031559 · Cited by 165
Tumor‐derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy
Aslan, C., Maralbashi, S., Salari, F., Kahroba, H., Sigaroodi, F., Kazemi, T., & Kharaziha, P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28374 · Cited by 160
Kleinerman, E. S., Jia, S. F., Griffin, J., Seibel, N. L., Benjamin, R. S., & Jaffe, N. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1310 · Cited by 157
TGF-β in cancer and bone: Implications for treatment of bone metastases
Juárez, P., & Guise, T. A. (2010) · Bone · doi:10.1016/j.bone.2010.08.004 · Cited by 156
Lassen, N. E., Andersen, T. L., Pløen, G. G., Søe, K., Hauge, E. M., Harving, S., Eschen, G. E. T., & Delaisse, J.-M. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3091 · Cited by 152
TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
Lamora, A., Talbot, J., Mullard, M., Royer, B. B.-L., Rédiní, F., & Verrecchia, F. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5110096 · Cited by 151
Self-citationGaspar, N., Occéan, B., Pacquement, H., Bompas, E., Bouvier, C., Brisse, H. J., Castex, M., Cheurfa, N., Corradini, N., Delaye, J., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.09.036 · Cited by 150
Fritzsching, B., Fellenberg, J., Moskovszky, L. E., Sápi, Z., Krenács, T., Machado, I., Poeschl, J., Lehner, B., Szendrői, M., Bosch, A. L., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990800 · Cited by 147
Wang, G., Sun, M., Jiang, Y., Zhang, T., Sun, W. Y., Wang, H., Yin, F., Wang, Z., Sang, W., Xu, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32180 · Cited by 147
Heymann, D., Ory, B., Blanchard, F., Heymann, M., Coipeau, P., Charrier, C., Couillaud, S., Thiery, J. P., Gouin, F., & Rédiní, F. (2005) · Bone · doi:10.1016/j.bone.2005.02.020 · Cited by 142
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
Bonuccelli, G., Avnet, S., Grisendi, G., Salerno, M., Granchi, D., Dominici, M., Kusuzaki, K., & Baldini, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2243 · Cited by 140
Verrecchia, F., & Rédiní, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00133 · Cited by 139
Self-citationMuramyl tripeptide (mifamurtide) for the treatment of osteosarcoma
Meyers, P. A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.69 · Cited by 134
Structure and Functions of Blood Vessels and Vascular Niches in Bone
Ramasamy, S. K. (2017) · Stem Cells International · doi:10.1155/2017/5046953 · Cited by 130
Zheng, Y., Wang, G., Chen, R., Hua, Y., & Cai, Z. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0780-x · Cited by 127
Yang, J., Yang, D., Sun, Y. K., Sun, B., Wang, G., Trent, J. C., Araujo, D. M., Chen, K., & Zhang, W. (2011) · Cancer · doi:10.1002/cncr.26116 · Cited by 125
Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs
Raimondi, L., Luca, A. D., Gallo, A., Costa, V., Russelli, G., Cuscino, N., Manno, M., Raccosta, S., Carina, V., Bellavia, D., et al. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz130 · Cited by 125
Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma
Lamora, A., Talbot, J., Bougras-Cartron, G., Amiaud, J., Leduc, M., Chesneau, J., Taurelle, J., Stresing, V., Deley, M. L., Heymann, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3191 · Cited by 124
Self-citationRutkowski, P. L., Kaminska, J. A., Kowalska, M. M., Ruka, W., & Steffen, J. A. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10305 · Cited by 120
Ali, O. H., Diem, S., Markert, E., Jochum, W., Kerl, K., French, L. E., Speiser, D. E., Früh, M., & Flatz, L. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1231292 · Cited by 119
Anti-angiogenesis target therapy for advanced osteosarcoma
Xie, L., Ji, T., & Guo, W. (2017) · Oncology Reports · doi:10.3892/or.2017.5735 · Cited by 119
Humbert, P., Brennan, M. Á., Davison, N., Rosset, P., Trichet, V., Blanchard, F., & Layrolle, P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00663 · Cited by 119
Self-citationBrennan, M. Á., Renaud, A., Amiaud, J., Rojewski, M., Schrezenmeier, H., Heymann, D., Trichet, V., & Layrolle, P. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt504 · Cited by 118
Self-citationAsmane, I., Watkin, E., Alberti, L., Duc, A., Marec‐Bérard, P., Ray-Coquard, I. L., Cassier, P. A., Decouvelaere, A., Ranchère‐Vince, D., Kurtz, J., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.05.009 · Cited by 115
Rainusso, N., Brawley, V. S., Ghazi, A., Hicks, M. J., Gottschalk, S., Rosen, J. M., & Ahmed, N. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2011.83 · Cited by 114
IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
Huang, X., Park, H., Greene, J., Pao, J., Mulvey, E., Zhou, S. X., Albert, C. M., Moy, F., Sachdev, D., Yee, D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133152 · Cited by 109
Genome‐wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma
Smida, J., Xu, H., Zhang, Y., Baumhoer, D., Ribi, S., Kovac, M. B., von Luettichau, I., Bielack, S., O’Leary, V. B., Leib‐Mösch, C., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30778 · Cited by 105
Ruiz, M., Toupet, K., Maumus, M., Rozier, P., Jørgensen, C., & Noël, D. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119544 · Cited by 99
Pietrovito, L., Leo, A., Gori, V., Lulli, M., Parri, M., Becherucci, V., Piccini, L., Bambi, F., Taddei, M. L., & Chiarugi, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12189 · Cited by 97
Endothelial Progenitor Cells in Tumor Angiogenesis: Another Brick in the Wall
Marçola, M., & Rodrigues, C. E. (2015) · Stem Cells International · doi:10.1155/2015/832649 · Cited by 96
Cleton-Jansen, A. M., Anninga, J., Bruijn, I. H. B., Romeo, S. O., Oosting, J., Egeler, R. M., Gelderblom, H. A. J., Taminiau, A. H. M., & Hogendoorn, P. C. W. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605405 · Cited by 94
Weber, B., Kimhi, S., Howard, G., Eden, A., & Lyko, F. (2010) · Oncogene · doi:10.1038/onc.2010.227 · Cited by 91
RANKL blockade prevents and treats aggressive osteosarcomas
Chen, Y., Grappa, M. A. D., Molyneux, S. D., McKee, T. D., Waterhouse, P. D., Penninger, J. M., & Khokha, R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad0295 · Cited by 91
Vallabhaneni, K. C., Hassler, M.-Y., Abraham, A., Whitt, J. D., Mo, Y., Atfi, A., & Pochampally, R. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166027 · Cited by 90
Zheng, B., Ren, T., Huang, Y., & Guo, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.032 · Cited by 89
Danieau, G., Morice, S., Rédiní, F., Verrecchia, F., & Royer, B. B.-L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153751 · Cited by 89
Self-citationLoss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases
Endo‐Munoz, L., Cumming, A., Rickwood, D., Wilson, D., Cueva, C., Ng, C. K. Y., Strutton, G., Cassady, A. I., Evdokiou, A., Sommerville, S. M. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4291 · Cited by 88
Ohba, T., Cole, H., Cates, J., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2182 · Cited by 86
Amjadi‐Moheb, F., & Akhavan‐Niaki, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28207 · Cited by 86
RANKL expression is related to treatment outcome of patients with localized, high‐grade osteosarcoma
Lee, J. A., Jung, J. S., Kim, D. H., Lim, J. S., Kim, M. S., Kong, C., Song, W. S., Cho, W. H., Jeon, D., Lee, S., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22720 · Cited by 85
Increased osteoclast activity is associated with aggressiveness of osteosarcoma
Avnet, S. (1992) · International Journal of Oncology · doi:10.3892/ijo_00000113 · Cited by 84
Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysis
Zhu, C., Ma, X., Hu, Y., Guo, L., Chen, B., Shen, K., & Xiao, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.10019 · Cited by 83
Endo‐Munoz, L., Cai, N., Cumming, A., Macklin, R., de Long, L. M., Topkas, E., Mukhopadhyay, P., Hill, M. M. C., & Saunders, N. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133592 · Cited by 82
Kaya, M., Wada, T., Kawaguchi, S., Nagoya, S., Yamashita, T., Abe, Y., Hiraga, H., Isu, K., Shindoh, M., Higashino, F., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600201 · Cited by 79
Goldstein, S. D., Trucco, M., Guzman, W. B., Hayashi, M., & Loeb, D. M. (2016) · Oncotarget · doi:10.18632/oncotarget.8522 · Cited by 78
Immunotherapy of Pediatric Solid Tumors: Treatments at a Crossroads, with an Emphasis on Antibodies
Casey, D. L., & Cheung, N. V. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0692 · Cited by 77
Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1
Weekes, D. B., Kashima, T. G., Zandueta, C., Perurena, N., Thomas, D. P., Sunters, A., Vuillier, C., Bozec, A., El‐Emir, E., Milétich, I., et al. (2015) · Oncogene · doi:10.1038/onc.2015.344 · Cited by 75
Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours
Inagaki, Y., Hookway, E. S., Williams, K., Hassan, A. B., Oppermann, U. C. T., Tanaka, Y., Soilleux, E. J., & Athanasou, N. A. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0053-3 · Cited by 74
Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis
Yu, X., Wu, T. Y., Xiang, Y., Wei-ping, R. E. N., Zhou, Z. B., Sun, Y., & Zhang, C. (2013) · Tumor Biology · doi:10.1007/s13277-013-1019-1 · Cited by 73
Fibroblast growth factors in skeletal development
Ornitz, D. M., & Marie, P. J. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.11.020 · Cited by 66
Chen, D., Zhang, Y., Zhu, K., et al. (2013) · Tumor Biology · doi:10.1007/s13277-013-0733-z · Cited by 65
Pazopanib in relapsed osteosarcoma patients: report on 15 cases
Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., Spinnato, P., Donati, D. M., Hompland, I., & Boye, K. (2018) · Acta Oncologica · doi:10.1080/0284186x.2018.1503714 · Cited by 65
Extracellular Vesicles of Stem Cells to Prevent BRONJ
Watanabe, J., Sakai, K., Urata, Y., Toyama, N., Nakamichi, E., & Hibi, H. (2020) · Journal of Dental Research · doi:10.1177/0022034520906793 · Cited by 65
Liu, T., Fang, X.-C., Ding, Z., Sun, Z.-G., Sun, L.-M., & Wang, Y.-L. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.08.002 · Cited by 64
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy
Navid, F., Santana, V. M., Neel, M. D., McCarville, M. B., Shulkin, B. L., Wu, J., Billups, C. A., Mao, S., Daryani, V. M., Stewart, C. F., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30841 · Cited by 62
Garimella, R., Washington, L., Isaacson, J., Vallejo, J. A., Spence, M., Tawfik, O. W., Rowe, P. S., Brotto, M., & Perez, R. P. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.04.011 · Cited by 60
Gaebler, M., Silvestri, A., Haybaeck, J., Reichardt, P., Lowery, C. D., Stancato, L. F., Zybarth, G., & Regenbrecht, C. R. A. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00203 · Cited by 60
Autocrine VEGF/VEGFR1 Signaling in a Subpopulation of Cells Associates with Aggressive Osteosarcoma
Ohba, T., Cates, J., Cole, H., Slosky, D., Haro, H., Ando, T., Schwartz, H. S., & Schoenecker, J. G. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0037 · Cited by 58
Gebraad, A., Kornilov, R., Kaur, S., Miettinen, S., Haimi, S. P., Peltoniemi, H. H., Mannerström, B., & Seppänen‐Kaijansinkko, R. (2018) · FEBS Journal · doi:10.1111/febs.14485 · Cited by 58
Cheng, L., Pandya, P. H., Liu, E., Chandra, P., Wang, L., Murray, M. E., Carter, J., Ferguson, M. J., Saadatzadeh, M. R., Bijangi‐Vishehsaraei, K., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0456-5 · Cited by 58
RANK and RANK ligand expression in primary human osteosarcoma
Branstetter, D. G., Rohrbach, K., Huang, L., Soriano, R., Tometsko, M. E., Blake, M., Jacob, A. P., & Dougall, W. C. (2015) · Journal of bone oncology · doi:10.1016/j.jbo.2015.06.002 · Cited by 57
Combination Therapy with Ifosfamide and Liposome-Encapsulated Muramyl Tripeptide
Kleinerman, E. S., Meyers, P. A., Raymond, A. K., Gano, J. B., Jia, S.-F., & Jaffe, N. (1995) · Journal of Immunotherapy · doi:10.1097/00002371-199504000-00007 · Cited by 57
Treating osteosarcoma with CAR T cells
Köksal, H., Müller, E., Inderberg, E. M., Bruland, Ø. S., & Wälchli, S. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12741 · Cited by 57
Vascular Endothelial Growth Factor Expression in Osteosarcoma
Charity, R., Foukas, A. F., Deshmukh, N., & Grimer, R. J. (2006) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000205877.05093.c9 · Cited by 55
Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients
Zhou, W., Zhou, W., Zheng, H., Du, X., Yang, J., Zheng, H., Du, X., & Yang, J. (2016) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2015.0102 · Cited by 54
Mei, J., Gao, Y., Zhang, L., et al. (2008) · PubMed · Cited by 53
Fioramonti, M., Fausti, V., Pantano, F., Iuliani, M., Ribelli, G., Lotti, F., Pignochino, Y., Grignani, G., Santini, D., Tonini, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22469-5 · Cited by 52
Navet, B., Ando, K., Vargas-Franco, J. W., Brion, R., Amiaud, J., Mori, K., Yagita, H., Mueller, C. G., Verrecchia, F., Dumars, C., et al. (2018) · Cancers · doi:10.3390/cancers10110398 · Cited by 52
Self-citationUrokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells
Vallabhaneni, K. C., Tkachuk, S., Kiyan, Y., Shushakova, N., Haller, H. G., Dumler, I., & Eden, G. C. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq362 · Cited by 51
Lammli, J., Fan, M., Rosenthal, H. G., et al. (2012) · International Orthopaedics · doi:10.1007/s00264-012-1629-z · Cited by 51
Exosomes in Bone Sarcomas: Key Players in Metastasis
Chicón‐Bosch, M., & Tirado, Ò. M. (2020) · Cells · doi:10.3390/cells9010241 · Cited by 50
Prognostic value of programmed death-ligand 1 in sarcoma: a meta-analysis
Zhu, Z., Jin, Z., Zhang, M., Tang, Y., Yang, G., Yuan, X., Yao, J., & Sun, D. (2017) · Oncotarget · doi:10.18632/oncotarget.19168 · Cited by 49
Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles
Mannerström, B., Kornilov, R., Abu-Shahba, A. G., Chowdhury, I. M., Sinha, S., Seppänen‐Kaijansinkko, R., & Kaur, S. (2019) · Epigenetics · doi:10.1080/15592294.2019.1585177 · Cited by 47
Obstacles to T cell migration in the tumor microenvironment
Nicolás‐Boluda, A., & Donnadieu, E. (2018) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2018.12.006 · Cited by 46
Rousseau, J., Escriou, V., Lamoureux, F., Brion, R., Chesneau, J., Battaglia, S., Amiaud, J., Scherman, D., Heymann, D., Rédiní, F., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.455 · Cited by 45
Self-citationCathomas, R. L., Rothermundt, C. A., Bode, B., Fuchs, B., von Moos, R., & Schwitter, M. (2014) · Oncology · doi:10.1159/000369975 · Cited by 42
Bone deposition, bone resorption, and osteosarcoma
de Toledo, S. R. C., Oliveira, I. D., Okamoto, O. K., Zago, M. A., Alves, M. T. D. S., Jesús-García, R., Macedo, C. R. P. D., & Petrilli, A. S. (2010) · Journal of Orthopaedic Research® · doi:10.1002/jor.21120 · Cited by 39
Tumour-Derived Extracellular Vesicles (EVs): A Dangerous “Message in A Bottle” for Bone
Cappariello, A., & Rucci, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194805 · Cited by 39
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience
Pedersen, N. A., Rossen, P. B., Rose, H. K., & Safwat, A. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.12.001 · Cited by 39
Avril, P., Le Nail, L.-R., Brennan, M. Á., Rosset, P., De Pinieux, G., Layrolle, P., Heymann, D., Perrot, P., & Trichet, V. (2016) · Journal of Bone Oncology · doi:10.1016/j.jbo.2015.11.002 · Cited by 38
Self-citationExtracellular Nanovesicles Secreted by Human Osteosarcoma Cells Promote Angiogenesis
Perut, F., Roncuzzi, L., Zini, N., Massa, A., & Baldini, N. (2019) · Cancers · doi:10.3390/cancers11060779 · Cited by 36
Genetically transforming human osteoblasts to sarcoma: development of an osteosarcoma model
Yang, Y., Yang, R. R., Roth, M. E., Piperdi, S., Zhang, W., Dorfman, H. D., Rao, P. H., Park, A., Tripathi, S., Freeman, C., et al. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.133 · Cited by 35
Zoledronic Acid: Pleiotropic Anti-Tumor Mechanism and Therapeutic Outlook for Osteosarcoma
Ouyang, Z., Li, H., Zhai, Z., Xu, J., Dass, C. R., Qin, A., & Dai, K. (2018) · Current Drug Targets · doi:10.2174/1573399811666150615145409 · Cited by 32
Denosumab: Current Use in the Treatment of Primary Bone Tumors
Savvidou, O. D., Bolia, I. K., Chloros, G. D., Papanastasiou, J., Koutsouradis, P., & Papagelopoulos, P. J. (2017) · Orthopedics · doi:10.3928/01477447-20170627-04 · Cited by 32
Nail, L. L., Brennan, M. Á., Rosset, P., Deschaseaux, F., Piloquet, P., Pichon, O., Caignec, C. L., Crenn, V., Layrolle, P., Hérault, O., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030707 · Cited by 32
Self-citationVasculogenesis Driven by Bone Marrow-Derived Cells Is Essential for Growth of Ewing's Sarcomas
Yu, L., Su, B., Hollomon, M. G., Deng, Y., Facchinetti, V., & Kleinerman, E. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2795 · Cited by 27
Cleton-Jansen, A. M., Anninga, J. K., Bruijn, I. H. B., Romeo, S., Oosting, J., Egeler, R. M., Gelderblom, H. A. J., Taminiau, A. H. M., & Hogendoorn, P. C. W. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605482 · Cited by 23
Lowery, C. D., Blosser, W. D., Dowless, M. S., Renschler, M., Perez, L. V., Stephens, J. R., Pytowski, B., Wasserstrom, H. A., Stancato, L. F., & Falcón, B. L. (2019) · Oncotarget · doi:10.18632/oncotarget.27148 · Cited by 22
Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL
Marley, K., Bracha, S., & Séguin, B. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.08.001 · Cited by 21
An, R., Schmid, R., Klausing, A., Robering, J. W., Weber, M., Bäuerle, T., Detsch, R., Boccaccini, A. R., Horch, R. E., Boos, A. M., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201800135rr · Cited by 21
Ren, K., Zhang, J., Gu, X., Wu, S., Shi, X., Ni, Y., Chen, Y., Lü, J., Gao, Z., Wang, C., et al. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.05.008 · Cited by 19
Massimini, M., Maria, R. D., Malatesta, D., Romanucci, M., D'Anselmo, A., & Salda, L. D. (2019) · Veterinary and Comparative Oncology · doi:10.1111/vco.12482 · Cited by 15
Cited by
Advancing therapy for osteosarcoma
Gill, J., & Gorlick, R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00519-8 · Cited by 876
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., Wang, Y., Zhang, Z., Yuan, T., Ding, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20059-6 · Cited by 672
Molecular Biology of Osteosarcoma
Czarnecka, A. M., Synoradzki, K., Firlej, W., Bartnik, E., Sobczuk, P., Fiedorowicz, M., Grieb, P., & Rutkowski, P. (2020) · Cancers · doi:10.3390/cancers12082130 · Cited by 336
Tumor-Associated Macrophages in Osteosarcoma: From Mechanisms to Therapy
Cersosimo, F., Lonardi, S., Bernardini, G., Telfer, B., Mandelli, G. E., Santucci, A., Vermi, W., & Giurisato, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155207 · Cited by 280
Advances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270
“Analyses of TME of osteosarcoma demonstrate an immune cell infiltrate consisting of both macrophages and T cells [53, 54].”
Background
Metadata
- Authors
- Corre, I., Verrecchia, F., Crenn, V., Redini, F., & Trichet, V.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-04-15
- Volume
- 9
- Issue
- 4
- Pages
- 976
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3017202750
- Cited by
- 474
- References
- 160
- FWCI
- 30.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.